NEW YORK (360Dx) – Concussion test development firm BioDirection today said that it closed $2 million interim financing to support clinical development of its diagnostic system.

Participants in the financing include Provident Healthcare Capital, MedScience Ventures, and others, the Boston-based firm said. In total, BioDirection has raised $12 million in outside funding since its founding in 2010.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.